BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 28932572)

  • 21. Chronic lung allograft dysfunction: evolving practice.
    Vos R; Verleden SE; Verleden GM
    Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
    Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
    Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.
    Horie M; Saito T; Moseley J; D'Errico L; Salazar P; Nakajima D; Brock K; Yasufuku K; Binnie M; Keshavjee S; Paul N
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
    Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
    Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of chronic lung allograft dysfunction phenotypes using spectral and intrabreath oscillometry.
    Fu A; Vasileva A; Hanafi N; Belousova N; Wu J; Rajyam SS; Ryan CM; Hantos Z; Chow CW
    Front Physiol; 2022; 13():980942. PubMed ID: 36277208
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development of Personalized and Targeted Preventive Therapies for Chronic Lung Allograft Dysfunction Subtypes;A Novel Strategy].
    Saito T; Sato M; Taniguchi Y; Murakawa T; Keshavjee S
    Kyobu Geka; 2016 Oct; 69(11):931-934. PubMed ID: 27713199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early chest CT abnormalities to predict the subsequent occurrence of chronic lung allograft dysfunction.
    Habert P; Chetrit E; Coiffard B; Bregeon F; Thomas P; Loundou A; Bermudez J; Reynaud-Gaubert M; Gaubert JY
    Insights Imaging; 2023 Sep; 14(1):154. PubMed ID: 37741923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome.
    Hota P; Dass C; Kumaran M; Simpson S
    AJR Am J Roentgenol; 2018 Jul; 211(1):W13-W21. PubMed ID: 29792746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome.
    Yoshiyasu N; Sato M
    World J Transplant; 2020 May; 10(5):104-116. PubMed ID: 32864356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new classification system for chronic lung allograft dysfunction.
    Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current views on chronic rejection after lung transplantation.
    Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
    Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung Transplantation.
    Koutsokera A; Royer PJ; Antonietti JP; Fritz A; Benden C; Aubert JD; Tissot A; Botturi K; Roux A; Reynaud-Gaubert ML; Kessler R; Dromer C; Mussot S; Mal H; Mornex JF; Guillemain R; Knoop C; Dahan M; Soccal PM; Claustre J; Sage E; Gomez C; Magnan A; Pison C; Nicod LP;
    Front Med (Lausanne); 2017; 4():109. PubMed ID: 28770204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct expression patterns of alveolar "alarmins" in subtypes of chronic lung allograft dysfunction.
    Saito T; Liu M; Binnie M; Sato M; Hwang D; Azad S; Machuca TN; Zamel R; Waddell TK; Cypel M; Keshavjee S
    Am J Transplant; 2014 Jun; 14(6):1425-32. PubMed ID: 24787265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
    McInnis MC; Ma J; Karur GR; Houbois C; Levy L; Havlin J; Fuchs E; Tikkanen J; Chow CW; Huszti E; Martinu T
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34949699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are we near to an effective drug treatment for bronchiolitis obliterans?
    Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
    Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?
    Snell GI; Paraskeva M; Westall GP
    Paediatr Drugs; 2013 Aug; 15(4):281-9. PubMed ID: 23605986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When tissue is the issue: A histological review of chronic lung allograft dysfunction.
    Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D
    Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.